Evidence map›Paper›PMID 35197468›Full record

ArticleScientific reports2022

Reproducible neuroimaging features for diagnosis of autism spectrum disorder with machine learning.

Cooper J Mellema, Kevin P Nguyen, Alex Treacher, Albert Montillo

Open access · goldAbstract readValidation Study
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 52 citations in OpenAlex.

  1. Efficacy and Safety of AltibrainCurrent pharmaceutical design · 2025
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Unsupervised Dimensionality Reduction Techniques for the Assessment of ASD Biomarkers.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. ASD-GResTM: Deep Learning Framework for ASD classification using Gramian Angular Field.Proceedings. IEEE International Conference on Bioinformatics and Biomedicine · 2023
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Cooper J MellemaLyda Hill Department of Bioinformatics, UT Southwestern, Dallas, USA.
Kevin P NguyenLyda Hill Department of Bioinformatics, UT Southwestern, Dallas, USA.
Alex TreacherLyda Hill Department of Bioinformatics, UT Southwestern, Dallas, USA.
Albert MontilloLyda Hill Department of Bioinformatics, UT Southwestern, Dallas, USA. Albert.Montillo@UTSouthwestern.edu.
The University of Texas Southwestern Medical Center · USSouthwestern Medical Center · US

Funding

Quantitative Non-Contrast Perfusion using Arterial Spin Labeling for Assessment of Cancer Therapy ResponseU01CA207091 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MADHURANTHAKAM, ANANTH J, MALDJIAN, JOSEPH A · 2017 to 2022
$3.1M
Blood Biomarker for Alzheimer's Disease: PhospholipidsRF1AG059288 · NIA · UT SOUTHWESTERN MEDICAL CENTER · PI GERMAN, DWIGHT C., MCDONALD, JEFF G · 2019 to 2019
$1.2M
Predicting Parkinson's Disease Progression Rate Using Causal Measures of Functional MRI with Deep Learning Predictive ModelsF31NS115348 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI MELLEMA, COOPER JAMES · 2019 to 2021
$104k
NCI NIH HHS U01 CA207091NIA NIH HHS R01AG059288NIA NIH HHS RF1 AG059288NINDS NIH HHS F31 NS115348
6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is the fourth most common neurodevelopmental disorder, with a prevalence of 1 in 160 children. Accurate diagnosis relies on experts, but such individuals are scarce. This has led to increasing interest in the development of machine learning (ML) models that can integrate neuroimaging features from functional and structural MRI (fMRI and sMRI) to help reveal central nervous system alterations characteristic of ASD. We optimized and compared the performance of 12 of the most popular and powerful ML models. Each was separately trained using 15 different combinations of fMRI and sMRI features and optimized with an unbiased model search. Deep learning models predicted ASD with the highest diagnostic accuracy and generalized well to other MRI datasets. Our model achieves state-of-the-art 80% area under the ROC curve (AUROC) in diagnosis on test data from the IMPAC dataset; and 86% and 79% AUROC on the external ABIDE I and ABIDE II datasets (with further improvement to 93% and 90% after supervised domain adaptation). The highest performing models identified reproducible putative biomarkers for accurate ASD diagnosis in accord with known ASD markers as well as novel cerebellar biomarkers. Such reproducibility lends credence to their tremendous potential for defining and using a set of truly generalizable ASD biomarkers that will advance scientific understanding of neuronal changes in ASD.

Indexed as

Machine LearningAdolescentAdultAutism Spectrum DisorderBrainChildFemaleHumansMagnetic Resonance ImagingMaleModels, PsychologicalNeuroimagingReproducibility of ResultsROC CurveYoung Adult

Identifiers

PMID35197468
PMCPMC8866395
OpenAlexW4221131958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.